tiprankstipranks
Trending News
More News >
iZafe Group AB (DE:M02)
:M02

iZafe Group AB (M02) Price & Analysis

Compare
1 Followers

M02 Stock Chart & Stats


Financials

M02 FAQ

What was iZafe Group AB’s price range in the past 12 months?
iZafe Group AB lowest stock price was <€0.01 and its highest was €0.03 in the past 12 months.
    What is iZafe Group AB’s market cap?
    iZafe Group AB’s market cap is €7.48M.
      When is iZafe Group AB’s upcoming earnings report date?
      iZafe Group AB’s upcoming earnings report date is Aug 29, 2025 which is in 57 days.
        How were iZafe Group AB’s earnings last quarter?
        iZafe Group AB released its earnings results on Apr 25, 2025. The company reported -€0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.001.
          Is iZafe Group AB overvalued?
          According to Wall Street analysts iZafe Group AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does iZafe Group AB pay dividends?
            iZafe Group AB does not currently pay dividends.
            What is iZafe Group AB’s EPS estimate?
            iZafe Group AB’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does iZafe Group AB have?
            iZafe Group AB has 321,136,170 shares outstanding.
              What happened to iZafe Group AB’s price movement after its last earnings report?
              iZafe Group AB reported an EPS of -€0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of iZafe Group AB?
                Currently, no hedge funds are holding shares in DE:M02

                Company Description

                iZafe Group AB

                iZafe Group AB (publ), a life-science company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated drug dispenser that handles dose bags, facilitates and enables independent medication, and reminds and alerts if the current dose is not taken at the right time. It serves consumers, and public and private-sector care providers in Sweden, the Nordic region, and internationally. The company was formerly known as MediRätt AB (publ) and changed its name to iZafe Group AB (publ) in May 2019. iZafe Group AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.
                Similar Stocks
                Company
                Price & Change
                Follow
                Clinical Laserthermia Systems AB Class B
                S2Medical AB Class B
                Qlife Holding AB
                AegirBio AB
                Scandinavian Real Heart AB
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis